Branchioma with a nested/organoid morphology: molecular profiling of a distinctive potentially misleading variant and reappraisal of potential relationship to CD34-positive/Rb1-deficient tumors of the neck
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu kazuistiky, časopisecké články
PubMed
37401932
PubMed Central
PMC10611845
DOI
10.1007/s00428-023-03592-9
PII: 10.1007/s00428-023-03592-9
Knihovny.cz E-zdroje
- Klíčová slova
- Androgen receptor, Branchioma, CD34, Ectopic hamartomatous thymoma, Head and neck, Neuroendocrine carcinoma-like, RB1 gene, Retinoblastoma,
- MeSH
- branchiom * patologie MeSH
- lidé MeSH
- nádory brzlíku MeSH
- nádory glandulární a epitelové MeSH
- nádory měkkých tkání * MeSH
- nádory sítnice * MeSH
- organoidy patologie MeSH
- represorové proteiny MeSH
- retinoblastom * genetika patologie MeSH
- senioři MeSH
- thymom MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- Názvy látek
- INSM1 protein, human MeSH Prohlížeč
- represorové proteiny MeSH
Branchioma (previously called ectopic hamartomatous thymoma, branchial anlage mixed tumor, or thymic anlage tumor) is a rare lower neck lesion with an adult male predominance and an uncertain histogenesis. Except for 4 cases, all branchiomas described in the literature were benign. Recently, HRAS mutation was detected in one case, but still little is known about the molecular genetic background of this rare entity. We herein report the histological, immunohistochemical, and molecular genetic analysis of a branchioma with a nested/organoid (neuroendocrine-like) morphology in a 78-year-old man. Histology revealed classical branchioma areas merging with nested/organoid cellular component lacking conventional features of malignancy. Immunohistochemistry was positive for high-molecular-weight cytokeratins. CD34 was expressed in the spindle cell component. Moreover, the tumor cells showed near-complete loss of retinoblastoma (RB1) expression (<1% of cells positive). All neuroendocrine markers (synaptophysin, chromogranin, and INSM1) were negative. Next-generation sequencing (TSO500 Panel) revealed 5 pathogenic/likely pathogenic mutations including 1 mutation in KRAS and 2 different mutations in each of MSH6 and PTEN. FISH and DNA sequencing were negative for RB1 gene alterations. To our knowledge, this is the first report of a branchioma showing misleading nested/organoid morphology and the first report on Rb1 immunodeficiency in this entity, in addition to multiple gene mutations revealed by NGS.
Bioptic Laboratory Ltd Pilsen Czech Republic
Molecular and Genetic Laboratory BiOptic Laboratory Ltd Pilsen Czech Republic
Pathology Department Regional Hospital Kolin JSC Kolin Czech Republic
Zobrazit více v PubMed
Jing H, Wang J, Wei H, et al. Ectopic hamartomatous thymoma: report of a case and review of literature Int J. Clin Exp Pathol. 2015;8:11776–11784. PubMed PMC
Smith PS, McClure J. Unusual subcutaneous mixed tumour exhibiting adipose, fibroblastic, and epithelial components. J Clin Pathol. 1982;35:1074–1077. doi: 10.1136/jcp.35.10.1074. PubMed DOI PMC
Rosai J, Limas C, Husband EM. Ectopic hamartomatous thymoma. A distinctive benign lesion of lower neck. Am J Surg Pathol. 1984;8:501–513. doi: 10.1097/00000478-198407000-00002. PubMed DOI
Sato K, Thompson LDR, Miyai K, et al. Ectopic hamartomatous thymoma: a review of the literature with report of new cases and proposal of a new name: biphenotypic branchioma. Head Neck Pathol. 2018;12:202–209. doi: 10.1007/s12105-017-0854-6. PubMed DOI PMC
Fetsch JF, Laskin WB, Michal M, et al. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor. Am J Surg Pathol. 2004;28:1360–1370. doi: 10.1097/01.pas.0000135518.27224.3f. PubMed DOI
Weissferdt A, Kalhor N, Petersson F, et al. Ectopic hamartomatous thymoma-new insights into a challenging entity: a clinicopathologic and immunohistochemical study of 9 cases. Am J Surg Pathol. 2016;40:1571–1576. doi: 10.1097/PAS.0000000000000699. PubMed DOI
WHO Classification of Tumours Editorial Board . Head and neck tumours. Lyon (France): International Agency for Research on Cancer; 2022.
Liang PI, Li CF, Sato Y, et al. Ectopic hamartomatous thymoma is distinct from lipomatous pleomorphic adenoma in lacking PLAG1 aberration. Histopathology. 2013;62:518–522. doi: 10.1111/his.12022. PubMed DOI
Weinreb I, O’Malley F, Ghazarian D. Ectopic hamartomatous thymoma: a case demonstrating skin adnexal differentiation with positivity for epithelial membrane antigen, androgen receptors, and BRST-2 by immunohistochemistry. Hum Pathol. 2007;38:1092–1095. doi: 10.1016/j.humpath.2007.01.029. PubMed DOI
Thompson LDR, Gagan J, Washington A, et al. Biphenotypic branchioma: a better name than ectopic hamartomatous thymoma for a neoplasm with HRAS mutation Head Neck Pathol. 2020;14:884–888. doi: 10.1007/s12105-020-01132-4. PubMed DOI PMC
Michal M, Rubin BP, Kazakov DV, et al. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor. Virchows Arch. 2020;477:219–230. doi: 10.1007/s00428-020-02774-z. PubMed DOI
Skalova A, Ptakova N, Santana T, et al. NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is “intraductal” correct? Am J Surg Pathol. 2019;43:1303–1313. doi: 10.1097/PAS.0000000000001301. PubMed DOI
Landrum MJ, Lee JM. Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence Nucleic Acids Res. 2018;46:D1062–D1067. doi: 10.1093/nar/gkx1153. PubMed DOI PMC
Michal M, Agaimy A, Contreras AL, et al. Dysplastic lipoma: a distinctive atypical lipomatous neoplasm with anisocytosis, focal nuclear atypia, p53 overexpression, and a lack of MDM2 gene amplification by FISH; a report of 66 cases demonstrating occasional multifocality and a rare association with retinoblastoma. Am J Surg Pathol. 2018;42:1530–1540. doi: 10.1097/PAS.0000000000001129. PubMed DOI
Fukunaga M. Ectopic hamartomatous thymoma: a case report with immunohistochemical and ultrastructural studies. APMIS. 2002;110:565–570. doi: 10.1034/j.1600-0463.2002.11007808.x. PubMed DOI
Weissferdt A, Moran CA. Spindle cell thymomas with neuroendocrine morphology: a clinicopathological and immunohistochemical study of 18 cases. Histopathology. 2014;65:111–118. doi: 10.1111/his.12376. PubMed DOI
Gleeson M, Herbert A, Richards A. Management of lateral neck masses in adults. BMJ. 2000;320:1521–1524. doi: 10.1136/bmj.320.7248.1521. PubMed DOI PMC
SD. B, N. UD (2020) Spindle cell lipoma. WHO Classification of Tumours of Soft Tissue and Bone Tumours, 5th ed. Lyon: IARC Press:29-30
Syed S, Martin AM, Haupt H, et al. Frequent detection of androgen receptors in spindle cell lipomas: an explanation for this lesion’s male predominance? Arch Pathol Lab Med. 2008;132:81–83. doi: 10.5858/2008-132-81-FDOARI. PubMed DOI
Kutzner H, Kaddu S, Kanitakis J, et al. Spindle cell-predominant trichodiscoma. In: Elder DE, Massi D, Scolyer RA, Willemze R, et al., editors. WHO Classification of Skin Tumours. 4. Lyon: IARC Press; 2018.
Michalova K, Kutzner H, Steiner P, et al. Spindle cell predominant trichodiscoma or spindle cell lipoma with adnexal induction? A study of 25 cases, revealing a subset of cases with RB1 heterozygous deletion in the spindle cell stroma. Am J Dermatopathol. 2019;41:637–643. doi: 10.1097/DAD.0000000000001358. PubMed DOI